Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The BUY prediction by Quitte finished with a performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -5.682% | -5.682% | 161.417% | 108.805% |
| iShares Core DAX® | -1,42 % | 8,92 % | 7,31 % | 49,21 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % | 36,65 % | 97,34 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % | 46,60 % | 64,98 % |
| iShares S&P 500 | 1,45 % | 10,91 % | 27,17 % | 68,77 % |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.